Statera Biopharma Stock Price Patterns

Intrinsic Valuation Low Real High 0.00 0.000096 50.01 Details

Naive Forecast Low Next High 0.000003 0.0002 52.05 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.0002 0.0002 0.0002 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Statera Biopharma. Your research has to be compared to or analyzed against Statera Biopharma's peers to derive any actionable benefits. When done correctly, Statera Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Statera Biopharma.

Statera Biopharma After-Hype Price Density Analysis

Statera Biopharma Estimiated After-Hype Price Volatility

Statera Biopharma Pink Sheet Price Outlook Analysis

Notes

Statera Biopharma Hype Timeline

Statera Biopharma is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -3.18. Statera is forecasted to decline in value after the next headline, with the price expected to drop to 9.1E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -8.89%, whereas the daily expected return is at this time at 10.25%. The volatility of related hype on Statera Biopharma is about 16790.32%, with the expected price after the next announcement by competition of -3.18. About 16.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Statera Biopharma recorded a loss per share of 0.76. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 28th of January 2015. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Statera Biopharma Basic Forecasting Models to cross-verify your projections.

Statera Biopharma Related Hype Analysis

Statera Biopharma Additional Predictive Modules

Most predictive techniques to examine Statera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Statera using various technical indicators. When you analyze Statera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Statera Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Statera Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Statera Biopharma based on analysis of Statera Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Statera Biopharma's price analysis, check to measure Statera Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Statera Biopharma is operating at the current time. Most of Statera Biopharma's value examination focuses on studying past and present price action to predict the probability of Statera Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Statera Biopharma's price. Additionally, you may evaluate how the addition of Statera Biopharma to your portfolios can decrease your overall portfolio volatility.